When Cancer Drugs Break the Heart’s Vascular Sensor Targeted cancer therapies known as tyrosine kinase inhibitors (TKIs) have transformed cancer...
blood
News ReleaseWednesday, September 18, 2024 NIH-supported clinical trial is the first positive trial for treatment of hereditary hemorrhagic telangiectasia.A clinical...
